amgen bet on $1.9-billion five prime deal to grow in asia-pacif oncolog market
(reuter) - drugmak amgen inc is bui five prime therapeut for about $1.9 billion to expand it line of gastric cancer drug candid and it presenc in asia-pacif, the compani said on thursdai.
